Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 1, 1997, Pages 29-31

  Peter Diego, R ^a   Mihalakakos, Paul J ^a   Hexum, Terry D ^a   Hill, Gary E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

aprotinin; cardiopulmonary bypass; interleukin 6; methylprednisolone

Indexed keywords

APROTININ; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE BLIND PROCEDURE;

EID: 0031048220     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90248-2     Document Type: Article

References (33)

1. Wilson I, Gillinov AM, Curtis WE, et al: Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart. Circulation 88:372-379, 1993
2. Sluiter W, Pietersma A, Lamers JMJ, et al: Leukocyte adhesion molecules on the vascular endothelium: Their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 22: S37-S44, 1993 (suppl 4)
3. Entman ML, Youker K, Shoji T, et al: Neutrophil induced oxidative injury of cardiac myocytes. J Clin Invest 90:1335-1345, 1992
4. Smith CW, Entman ML, Lane CL, et al: Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J Clin Invest 88:1216-1233, 1991
5. Kukielka GL, Smith CW, Manning AM, et al: Induction of interleukin-6 synthesis in the myocardium. Circulation 92:1866-1875, 1995
6. Carlos TM, Harlán JM: Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 114:5-28, 1990
7. Teoh KHT, Bradley CA, Gauldie J, et al: Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 92: II347-11353, 1995 (suppl 2)
8. Hennein HA, Ebba H, Rodriguez JL, et al: Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108:626-635, 1994
9. Hill GE, Snider S, Galbraith T, et al: Glucocorticoids reduce bronchial epithelial inflammation during cardiopulmonary bypass. Am J Resp Crit Care Med 152:1791-1795, 1995
10. Whitten CW, Latson TW, Allison PM: Does aprotinin inhibit cardiopulmonary bypass induced inflammation? Anesthesiology 77: A266, 1992
11. Muylle L, Joos M, Wouters E, et al: Increased turmor necrosis factor α (TNF α), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF α and IL-6 levels and febrile transfusion reactions. Transfusion 33:195-199, 1993
12. Van der Meer JW, Enders S, Lonneman G, et al: Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leuk Biol 43:216-223, 1988
13. Hill GE, Alonso A, Thiele GM, et al: Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg 79:23-27, 1994
14. Arnaout MA: Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75:1037-1050, 1990
15. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell 62:3-6, 1990
16. Kilbride PM, Mayer JE, Newberger JW, et al: Induction of intercellular adhesion molecule and E-selectin nRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 107:1183-1192, 1994
17. Ruggeroli AC, Carruthers RG, Pohorecki R, et al: Cardiopulmo-nary bypass-induced inflammation: Steroids vs. aprotinin. Anesthesiology 83: A83, 1995
18. Jansen NJG, van Oeuveren W, Broek L: Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 102:515-525, 1991
19. Niazi Z, Flodin P, Joyce L, et al: Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest 76:262-268, 1979
20. Wachtfogel YT, Kucich U, et al: Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 106:1-10, 1993
21. Tumen J, Meyrick B, Berry L, et al: Antiproteinases protect cultured lung endothelial cells from endotoxin injury. J Appl Physiol 65:835-843, 1988
22. Pinsky MR, Vincent JL, Deviere J: Serum cytokine levels in human septic shock. Chest 103:565-575, 1993
23. Hettmannsperger U, Detmar M, Owsianowski M, et al: Cytokinestimulated human dermal microvascular endothelial cells produce interleukin-6 - inhibition by hydrocortisone, dexamethasone, and calcitriol. J Invest Derm 99:531-536, 1992
24. Rock CS, Coyle SM, Keogh CV: Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans. Surgery 112:467-474, 1992
25. Schindler R, Mancilla J, Endres S, et al: Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47, 1990
26. Kim KU, Kwon OJ, Jue DM: Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate. Immunol 80:134-139, 1993
27. Shakhov AN, Collart MA, Vassalli P, et al: κB-type enhancers are involved in lipopolysaccharid́e-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 171:35-47, 1990
28. Kim H, Lee HS, Chang KT, et al: Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB. J Immunol 154:4741-4748, 1995
29. Steinberg JB, Kapelanski DP, Olson JD, et al: Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:1008-1016, 1993
30. Butler J, Chong GL, Baigrie RI, et al: Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 53:833-838, 1992
31. Frering B, Philip I, Dehoux M, et al: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108:636-641, 1994
32. Hardy JF, Desroches J: Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 39:353-365, 1992
33. Schonberger J, Everts P, Ercan H, et al: Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood savings. Ann Thorac Surg 54:1172-1176, 1992